PhaseBio Pharmaceuticals Inc (PHAS) Insider Trading
- $1,730,020.00
- $361,082.53
- Oct. 25, 2022
- Clay Thorp
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Oct. 25, 2022 | Major Shareholder | 1,784,109 | $0.15 | Sell | $267,616.35 | |
| May 23, 2022 | SVP | 11,248 | $0.79 | Sell | $8,885.92 | |
| Nov. 19, 2021 | VP | 5,766 | $2.37 | Sell | $13,665.42 | |
| Aug. 18, 2021 | Director | 10,000 | $3.00 | Buy | $30,000.00 | |
| May 20, 2021 | VP | 3,811 | $3.29 | Sell | $12,538.19 | |
| Dec. 3, 2020 | Director | 6,000 | $4.12 | Buy | $24,720.00 | |
| Nov. 24, 2020 | Director | 5,000 | $3.60 | Buy | $18,000.00 | |
| Nov. 23, 2020 | VP | 3,497 | $3.45 | Sell | $12,064.65 | |
| July 1, 2019 | Director | 2,908 | $14.00 | Sell | $40,712.00 | |
| June 18, 2019 | Director | 400 | $14.00 | Sell | $5,600.00 | |
| Dec. 17, 2018 | Director | 1,000 | $4.46 | Buy | $4,460.00 | |
| Dec. 13, 2018 | CEO | 1,000 | $3.69 | Buy | $3,690.00 | |
| Dec. 11, 2018 | VP | 1,500 | $3.88 | Buy | $5,820.00 | |
| Dec. 10, 2018 | CEO | 3,000 | $3.87 | Buy | $11,610.00 | |
| Dec. 7, 2018 | CFO | 5,000 | $3.84 | Buy | $19,200.00 | |
| Dec. 4, 2018 | Director | 4,000 | $3.13 | Buy | $12,520.00 | |
| Oct. 22, 2018 | Director | 20,000 | $5.00 | Buy | $100,000.00 | |
| Oct. 22, 2018 | Major Shareholder | 300,000 | $5.00 | Buy | $1,500,000.00 |
Insiders are both buying and selling PhaseBio Pharmaceuticals Inc stock.
The insider traders at PhaseBio Pharmaceuticals Inc are: Clay Thorp, Glen Burkhardt, Jonathan P Mow, Enterprise Associates 13 L New, John P Sharp, Edmund Harrigan, Linda Tufts, Michael York, Nancy J Hutson, and Venture Advisors Iii Hatteras
The most active insider trader at PhaseBio Pharmaceuticals Inc is Clay Thorp with 5 trades.
Enterprise Associates 13 L New has sold the most PhaseBio Pharmaceuticals Inc stock with a total value of $535,232.70.
Venture Advisors Iii Hatteras has bought the most PhaseBio Pharmaceuticals Inc stock with a total value of $3,000,000.00.
The most recent insider trade for PhaseBio Pharmaceuticals Inc was on Oct. 25, 2022.
The single biggest insider buy for PhaseBio Pharmaceuticals Inc was from Venture Advisors Iii Hatteras with a total value of $1,500,000.00 on Oct. 22, 2018.
The single biggest insider sell for PhaseBio Pharmaceuticals Inc was from Enterprise Associates 13 L New with a total value of $267,616.35 on Oct. 25, 2022.